Kerry Associates, Inc. announces that the company has received a LOI for $30 Million Dollars in Financing on behalf of Amelot Holdings, Inc. (Pink Sheets: AMHD). Based upon initial due diligence and information provided to Remington Financial Group, a letter of interest to Finance $30 million dollars for Amelots Bio-Diesel division was received on Friday May 5th. Eric Cousens, President of Kerry Associates stated "This is a non dilutive financing. We have received numerous inquiries over the last few weeks from investors, venture capitalist and joint venture prospects since we started our campaign to raise capital for Amelot Holdings. Our strategy is to put Amelot and its shareholders in the forefront of the Bio-Diesel Industry. The progress being made has exceeded all our expectations." About Amelot Holdings, Inc. Amelot Holdings, Inc. is a diversified holding company focused on acquiring under-valued, high-growth firms and properties in the natural resource industry. For more information on Amelot Holdings Inc. Visit: www.amelotholdings.com About Kerry Associates, Inc. Kerry Associates Inc. is a business consulting firm helping companies develop and expand into emerging markets while strategically executing their objectives. For more information on Kerry Associates Inc. Visit: www.kerryassociates.com Statements in this press release that are not historical facts are forward-looking statements within the meaning of the Securities Act of 1933, as amended. Those statements include statements regarding the intent, belief or current expectations of the Company and its management. Such statements reflect management's current views, are based on certain assumptions and involve risks and uncertainties. Actual results, events, or performance may differ materially from the above forward-looking statements due to a number of important factors, and will be dependent upon a variety of factors, including, but not limited to, our ability to obtain additional financing and access funds from our existing financing arrangements that will allow us to continue our current and future operations and whether demand for our products and services in domestic and international markets will continue to expand. The Company undertakes no obligation to publicly update these forward-looking statements to reflect events or circumstances that occur after the date hereof or to reflect any change in the Company's expectations with regard to these forward-looking statements or the occurrence of unanticipated events.
HLK Biotech (CE) (USOTC:AMHD)
Graphique Historique de l'Action
De Nov 2024 à Déc 2024 Plus de graphiques de la Bourse HLK Biotech (CE)
HLK Biotech (CE) (USOTC:AMHD)
Graphique Historique de l'Action
De Déc 2023 à Déc 2024 Plus de graphiques de la Bourse HLK Biotech (CE)